SphenoTech Co., Ltd. (SphenoTech) is a provider of specialized chiral molecules, including chiral catalysts, chiral synthetic building blocks, and pharmaceutical intermediates. SphenoTech is based in Hong Kong and has production facilities in mainland China. Our products are essentially based on a special type of spirocyclic structures derived from SPHENOL and related skeletons licensed from the Hong Kong University of Science and Technology. SphenoTech also provides a broad portfolio of SPHENOL-related services including custom synthesis of chiral catalysts and small- and large-scale synthesis of APIs for R&D use.
SphenoTech engages all customer interactions in the highest ethical manner with transparency and accountability. We guard the IP of our clients with the strictest confidentiality. We strive to help our clients to achieve success with our expertise and dedication, from high-performance catalysts to cost-effective synthesis. SphenoTech is also open to any collaboration proposals by our clients.
SphenoTech is co-founded by the Hong Kong University of Science and Technology (HKUST) through IP rights and also partially sponsored by the Hong Kong government.
